全文获取类型
收费全文 | 99880篇 |
免费 | 9971篇 |
国内免费 | 7366篇 |
专业分类
耳鼻咽喉 | 717篇 |
儿科学 | 1137篇 |
妇产科学 | 943篇 |
基础医学 | 10683篇 |
口腔科学 | 1676篇 |
临床医学 | 12826篇 |
内科学 | 13806篇 |
皮肤病学 | 823篇 |
神经病学 | 5167篇 |
特种医学 | 3881篇 |
外国民族医学 | 59篇 |
外科学 | 10569篇 |
综合类 | 19558篇 |
现状与发展 | 19篇 |
一般理论 | 16篇 |
预防医学 | 7710篇 |
眼科学 | 2170篇 |
药学 | 11034篇 |
103篇 | |
中国医学 | 6375篇 |
肿瘤学 | 7945篇 |
出版年
2024年 | 308篇 |
2023年 | 1402篇 |
2022年 | 3419篇 |
2021年 | 4855篇 |
2020年 | 3860篇 |
2019年 | 3105篇 |
2018年 | 3342篇 |
2017年 | 3221篇 |
2016年 | 2878篇 |
2015年 | 4672篇 |
2014年 | 5733篇 |
2013年 | 5629篇 |
2012年 | 8257篇 |
2011年 | 9189篇 |
2010年 | 6188篇 |
2009年 | 5146篇 |
2008年 | 5959篇 |
2007年 | 5836篇 |
2006年 | 5585篇 |
2005年 | 5181篇 |
2004年 | 3630篇 |
2003年 | 3158篇 |
2002年 | 2775篇 |
2001年 | 2174篇 |
2000年 | 2043篇 |
1999年 | 1830篇 |
1998年 | 1172篇 |
1997年 | 1124篇 |
1996年 | 880篇 |
1995年 | 782篇 |
1994年 | 580篇 |
1993年 | 436篇 |
1992年 | 461篇 |
1991年 | 369篇 |
1990年 | 339篇 |
1989年 | 333篇 |
1988年 | 268篇 |
1987年 | 239篇 |
1986年 | 203篇 |
1985年 | 189篇 |
1984年 | 92篇 |
1983年 | 66篇 |
1982年 | 48篇 |
1981年 | 42篇 |
1980年 | 31篇 |
1979年 | 34篇 |
1978年 | 19篇 |
1974年 | 12篇 |
1971年 | 14篇 |
1970年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
31.
32.
毛细胞白血病(HCL)是一种以脾大、全血细胞减少、骨髓组织增生等为临床表现的罕见慢性B淋巴细胞增殖性疾病。克拉屈滨作为其一线药物,对HCL的完全缓解率很高。本文报道了2017-09-04绍兴市人民医院收治的1例经典型HCL患者在克拉屈滨治疗期间,出现严重粒细胞缺乏伴高热,合并全身皮疹及间质性肺炎,经大剂量激素等治疗后好转的诊疗过程。并结合文献回顾了HCL的诊断及治疗方法,简述了克拉屈滨治疗HCL致间质性肺炎这一少见并发症的诊疗思路,以提高临床医师对该毒副作用的认识,为临床工作提供帮助。 相似文献
33.
34.
摘要:抗生素的研发与使用有效杀灭和抑制了众多病原菌,挽救了无数人的生命,但由于抗生素的不合理使用,导致细菌耐
药不断出现,耐药菌的感染已严重地威胁人类的生命健康。为此,本文主要对近年来临床上常用的抗生素如β-内酰胺类、喹诺酮
类、氨基糖苷类药物以及新型抗菌药物如抗菌肽和纳米颗粒的应用研究进行总结分析与探讨,为临床上治疗疾病提供一些参考。 相似文献
35.
36.
目的观察关节镜下采用自体腘绳肌腱经胫骨隧道前交叉韧带(anterior cruciate ligament, ACL)双束八股解剖重建的临床效果。方法随访上海交通大学附属第六人民医院运动医学科2018年12月—2020年1月收治的103例ACL断裂患者资料,其中男78例,女25例,年龄18~45岁,平均(26.8±5.86)岁;左侧47例,右侧56例,均采用关节镜下自体腘绳肌腱经胫骨隧道打股骨骨隧道,ACL双束八股解剖重建。按照Lysholm评分、国际膝关节评分委员会(IKDC)膝关节评分、Tegner膝关节评分标准和膝关节自我效能量表K-SES评价疗效。结果所有患者术后获随访12~42个月,平均(24±8.18)个月;手术前、末次随访评分比较,Lysholm评分分别为(48.41±4.44)分和(95.34±1.91)分,2组比较差异有统计学意义(P<0.001);IKDC评分分别为(44.05±4.36)分和(95.66±1.89)分,2组比较差异有统计学意义(P<0.001);Tegner评分分别为(2.84±0.95)分和(6.15±0.89)分,2组比较差异有统计学意义(P<0.001);膝关节自我效能量表K-SES量表(3.10±0.83)分和(7.12±1.10)分,2组比较差异有统计学意义(P<0.001)。末次随访103例患者前抽屉试验阴性,轴移试验阴性。98例(95.1%)Lachman试验阴性,5例(4.9%)Lachman试验1°阳性。结论关节镜下采用自体腘绳肌腱经胫骨隧道双束八股解剖重建前交叉韧带是一种恢复膝关节稳定性,恢复伤前活动水平的有效方法。 相似文献
37.
Yi Li Ying Chen Xiang Li Jian Wu Jing-Ying Pan Ri-Xin Cai Ri-Yun Yang Xiao-Dong Wang 《中国神经再生研究》2019,(9)
In the search for a therapeutic schedule for spinal cord injury, it is necessary to understand key genes and their corresponding regulatory networks involved in the spinal cord injury process. However, ad hoc selection and analysis of one or two genes cannot fully reveal the complex molecular biological mechanisms of spinal cord injury. The emergence of second-generation sequencing technology(RNA sequencing) has provided a better method. In this study, RNA sequencing technology was used to analyze differentially expressed genes at different time points after spinal cord injury in rat models established by contusion of the eighth thoracic segment. The numbers of genes that changed significantly were 944, 1362 and 1421 at 1, 4 and 7 days after spinal cord injury respectively. After gene ontology analysis and temporal expression analysis of the differentially expressed genes, C5ar1, Socs3 and CCL6 genes were then selected and identified by real-time polymerase chain reaction and western blot assay. The mRNA expression trends of C5ar1, Socs3 and CCL6 genes were consistent with the RNA sequencing results. Further verification and analysis of C5ar1 indicate that the level of protein expression of C5ar1 was consistent with its nucleic acid level after spinal cord injury. C5ar1 was mainly expressed in neurons and astrocytes. Finally, the gene Itgb2,which may be related to C5ar1, was found by Chilibot database and literature search. Immunofluorescence histochemical results showed that the expression of Itgb2 was highly consistent with that of C5ar1. Itgb2 was expressed in astrocytes. RNA sequencing technology can screen differentially expressed genes at different time points after spinal cord injury. Through analysis and verification, genes strongly associated with spinal cord injury can be screened. This can provide experimental data for further determining the molecular mechanism of spinal cord injury, and also provide possible targets for the treatment of spinal cord injury. This study was approved ethically by the Laboratory Animal Ethics Committee of Jiangsu Province, China(approval No. 2018-0306-001) on March 6, 2018. 相似文献
38.
39.
Discoid lupus erythematosus (DLE) is the most common skin manifestation of lupus; however, the molecular mechanisms underlying DLE remain unknown. Therefore, we aimed to identify key differentially expressed genes (DEGs) in discoid lupus skin and investigate their potential pathways.To identify candidate genes involved in the occurrence and development of the disease, we downloaded the microarray datasets and GSE52471 from the Gene Expression Database (GEO). DEGs between discoid lupus skin and normal controls were selected using the GEO2R tool and Venn diagram software ( GSE72535http://bioinformatics.psb.ugent.be/webtools/Venn/). The Database for Annotation, Visualization, and Integrated Discovery (DAVID), Enrichr, and Cytoscape ClueGo were used to analyze the Kyoto Encyclopedia of Gene and Genome pathways and gene ontology. Protein-protein interactions (PPIs) of these DEGs were further assessed using the Search Tool for the Retrieval Interacting Genes version 10.0.Seventy three DEGs were co-expressed in both datasets. DEGs were predominantly upregulated in receptor signaling pathways of the immune response. In the PPI network, 69 upregulated genes were selected. Furthermore, 4 genes (CXCL10, ISG15, IFIH1, and IRF7) were found to be significantly upregulated in the RIG-I-like receptor signaling pathway, from analysis of Enrichr and Cytoscape ClueGo.The results of this study may provide new insights into the potential molecular mechanisms of DLE. However, further experimentation is required to confirm these findings. 相似文献
40.
Xiaojie Wu Leyan Zhang Jiadi Zhou Luying Liu Qiang Fu Aili Fu Xiaoying Feng Rui Xin Hongrui Liu Yong Gao Jiangnan Xue 《Current problems in cancer》2019,43(1):18-26